Authors:
Enting, RH
Prins, JM
Jurriaans, S
Brinkman, K
Portegies, P
Lange, JMA
Citation: Rh. Enting et al., Concentrations of human immunodeficiency virus type 1 (HIV-1) RNA in cerebrospinal fluid after antiretroviral treatment initiated during primary HIV-1 infection, CLIN INF D, 32(7), 2001, pp. 1095-1099
Authors:
Frissen, PHJ
de Vries, J
Weigel, HM
Brinkman, K
Citation: Phj. Frissen et al., Severe anaphylactic shock after rechallenge with abacavir without preceding hypersensitivity, AIDS, 15(2), 2001, pp. 289-289
Citation: Ua. Walker et K. Brinkman, An argument for mitochondrial toxicity in highly active antiretroviral therapy-induced lipoatrophy, AIDS, 15(11), 2001, pp. 1450-1452
Authors:
Frissen, PHJ
de Vries, J
Weigel, HM
Brinkman, K
Citation: Phj. Frissen et al., Reply to 'The abacavir hypersensitivity reaction and interruptions in therapy' by A. Edde Loeliger, Helen Steel, Sue McGuirk, Wendy S. Powell and Seth V. Hetherington, AIDS, 15(10), 2001, pp. 1326-1326
Citation: K. Brinkman, Editorial response: Hyperlactatemia and hepatic steatosis as features of mitochondrial toxicity of nucleoside analogue reverse transcriptase inhibitors, CLIN INF D, 31(1), 2000, pp. 167-169
Authors:
ter Hofstede, HJM
de Marie, D
Foudraine, NA
Danner, SA
Brinkman, K
Citation: Hjm. Ter Hofstede et al., Clinical features and risk factors of lactic acidosis following long-term antiretroviral therapy: 4 fatal cases, INT J STD A, 11(9), 2000, pp. 611-616
Citation: K. Brinkman et Tn. Kakuda, Mitochondrial toxicity of nucleoside analogue reverse transcriptase inhibitors: a looming obstacle for long-term antiretroviral therapy?, CURR OPIN I, 13(1), 2000, pp. 5-11
Authors:
Gisolf, EH
Jurriaans, S
Pelgrom, J
van Wanzeele, F
van der Ende, ME
Brinkman, K
Borst, MJ
de Wolf, F
Japour, AJ
Danner, SA
Citation: Eh. Gisolf et al., The effect of treatment intensification in HIV-infection: a study comparing treatment with ritonavir/saquinavir and ritonavir/saquinavir/stavudine, AIDS, 14(4), 2000, pp. 405-413
Authors:
Hugen, PWH
Burger, DM
de Graaff, M
ter Hofstede, HJM
Hoetelmans, RMW
Brinkman, K
Meenhorst, PL
Mulder, JW
Koopmans, PP
Hekster, YA
Citation: Pwh. Hugen et al., Saliva as a specimen for monitoring compliance but not for predicting plasma concentrations in patients with HIV treated with indinavir, THER DRUG M, 22(4), 2000, pp. 437-445
Authors:
Burling, K
Seguin, MA
Marsh, P
Brinkman, K
Madigan, J
Thurmond, M
Moon-Massat, P
Mannis, M
Murphy, CJ
Citation: K. Burling et al., Effect of topical administration of epidermal growth factor on healing of corneal epithelial defects in horses, AM J VET RE, 61(9), 2000, pp. 1150-1155
Authors:
Brinkman, K
Smeitink, JA
Romijn, JA
Reiss, P
Citation: K. Brinkman et al., Mitochondrial toxicity induced by nucleoside-analogue reverse-transcriptase inhibitors is a key factor in the pathogenesis of antiretroviral-therapy-related lipodystrophy, LANCET, 354(9184), 1999, pp. 1112-1115
Authors:
Burger, DM
Hoetelmans, RMW
Hugen, PWH
Mulder, JW
Meenhorst, PL
Koopmans, PP
Brinkman, K
Keuter, M
Dolmans, W
Hekster, YA
Citation: Dm. Burger et al., Low plasma concentrations of indinavir are related to virological treatment failure in HIV-1-infected patients on indinavir-containing triple therapy, ANTIVIR TH, 3(4), 1998, pp. 215-220
Citation: K. Brinkman et al., Highly active antiretroviral therapy (HAART) and prolonged survival of a patient with an HIV-related Burkitt lymphoma, despite an intracardiac relapse, INT J STD A, 9(12), 1998, pp. 773-775